Buy Stocks Easy | About Us

January 29, 2022

MNTA

Buy Momenta Pharmaceuticals, Inc. Stock (symbol: MNTA) Easy Online

Company Name: Momenta Pharmaceuticals, Inc.

Symbol: MNTA

Sector: Health Care

Industry: Biotechnology: Biological Products (No Diagnostic Substances)

IPO: 2004

MNTA Current Share Price

Today's MNTA ( Momenta Pharmaceuticals, Inc. ) opening price: $19.3000

Yesterday's MNTA ( Momenta Pharmaceuticals, Inc. ) closing price: $19.1400

Momenta Pharmaceuticals, Inc. Stock ( symbol: MNTA ) Price Chart since IPO (2004):

12 Months Momenta Pharmaceuticals, Inc. Stock ( symbol: MNTA ) Price Chart

Popular Questions about Momenta Pharmaceuticals, Inc. Public Stock ( MNTA )

A: Momenta Pharmaceuticals, Inc. stock symbol (also called stock or share ticker) is MNTA

A: Momenta Pharmaceuticals, Inc. IPO (Initial Public Offering) took place on 2004

A: Momenta Pharmaceuticals, Inc.'s stock (MNTA symbol) price at ther IPO (initial Public Offering) was $19.3000

Q: Is MNTA stock worth buying at the moment?

A: If you were looking for a long-term investment portfolio and had bought the 'Momenta Pharmaceuticals, Inc. stock (symbol: MNTA) at the beginning of 2019, at the opening share price of $11.8600, with a minimum of $200, by now your shares would be worth $3572 and your profit would be $3372 - SHOW ONLY IF PROFIT.

Buy Momenta Pharmaceuticals, Inc. Stock Easy Online

Momenta Pharmaceuticals, Inc. Stock Ticker Price Chart since IPO:

Momenta Pharmaceuticals, Inc. Stock Price Yesterday

Momenta Pharmaceuticals, Inc. Stock Price – Last Week

Momenta Pharmaceuticals, Inc. Stock Price – Last Month

Momenta Pharmaceuticals, Inc. Stock Value Chart – 12 Months

Rate this post

Latest Stock News:

http://www.globenewswire.com/news-release/2020/01/13/1969451/0/en/Momenta-Provides-Year-End-2019-Update-and-2020-Outlook.html

Momenta Provides Year-End 2019 Update and 2020 Outlook

-- Interim Phase 1 / 2 data of M254 in ITP supports expansion of lo...

http://www.globenewswire.com/news-release/2020/01/03/1965997/0/en/Momenta-Pharmaceuticals-Announces-CFO-Transition.html

Momenta Pharmaceuticals Announces CFO Transition

Young Kwon, Ph.D. Appointed Chief Financial Officer Effective Janua...

http://www.zacks.com/stock/news/668845/momenta-pharmaceuticals-mnta-catches-eye-stock-jumps-71

Momenta Pharmaceuticals (MNTA) Catches Eye: Stock Jumps 7.1%

Momenta Pharmaceuticals (MNTA) saw a big move last session, as its ...

http://www.globenewswire.com/news-release/2019/12/13/1960389/0/en/Momenta-Pharmaceuticals-Appoints-Dr-Jane-F-Barlow-to-Board-of-Directors.html

Momenta Pharmaceuticals Appoints Dr. Jane F. Barlow to Board of Directors

CAMBRIDGE, Mass., Dec. 13, 2019 (GLOBE NEWSWIRE) -- Momenta Phar...

http://www.globenewswire.com/news-release/2019/12/12/1959822/0/en/Momenta-Pharmaceuticals-Announces-Pricing-of-Public-Offering-of-Common-Stock.html

Momenta Pharmaceuticals Announces Pricing of Public Offering of Common Stock

CAMBRIDGE, Mass., Dec. 12, 2019 (GLOBE NEWSWIRE) -- Momenta Pharm...

https://www.fool.com/investing/2019/12/11/heres-why-momenta-pharmaceuticals-dropped-today.aspx

Here’s Why Momenta Pharmaceuticals Stock Dropped Today

Investors are worried about the biotech raising cash.

https://247wallst.com/investing/2019/12/11/5-top-suntrust-stock-picks-for-2020-with-massive-upside-potential/

5 Top SunTrust Stock Picks for 2020 With Massive Upside Potential

What a year 2019 was for investors. The major indexes are all up ov...

http://www.globenewswire.com/news-release/2019/12/10/1958898/0/en/Momenta-Pharmaceuticals-Announces-Proposed-Public-Offering-of-Common-Stock.html

Momenta Pharmaceuticals Announces Proposed Public Offering of Common Stock

CAMBRIDGE, Mass., Dec. 10, 2019 (GLOBE NEWSWIRE) -- Momenta Pharm...

https://seekingalpha.com/article/4301058-momenta-pharmaceuticals-inc-mnta-ceo-craig-wheeler-q3-2019-results-earnings-call-transcript

Momenta Pharmaceuticals, Inc. (MNTA) CEO Craig Wheeler on Q3 2019 Results - Earnings Call Transcript

Momenta Pharmaceuticals, Inc. (MNTA) CEO Craig Wheeler on Q3 2019 R...

http://www.zacks.com/stock/news/595198/momenta-pharmaceuticals-mnta-reports-q3-loss-tops-revenue-estimates

Momenta Pharmaceuticals (MNTA) Reports Q3 Loss, Tops Revenue Estimates

Momenta (MNTA) delivered earnings and revenue surprises of -14.29% ...

All right reserved Buy Stocks Easy , 2019.